Biotech

All Articles

ReNeuron leaving behind AIM substitution after missing out on fundraising goal

.ReNeuron has joined the long checklist of biotechs to leave behind Greater london's objective stock...

MBX apply for IPO to take challenger to Ascendis into period 3

.MBX Biosciences has added to the recent spurt of IPO filings. The biotech, which submitted its docu...

FDA grows probe right into Lykos' MDMA tests: WSJ

.For Lykos Therapeutics as well as the company's potential MDMA-assisted treatment for post-traumati...

Gene editor Tome giving up 131 laborers

.Merely days after gene editor Volume Biosciences announced concealed operational cuts, a clearer pi...

Repare lays off 25% of team as biotech halts preclinical R&ampD

.Repare Therapy is laying off an one-fourth of its staff as the oncology biotech downsize its own pr...

J &amp J files for FDA permission of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten an additional measure towards realizing a return on its own $6.5 bi...

Gain's stage 1 gain paves method to verify Parkinson's drug's worth

.Increase Therapies has set its sights on confirming the effectiveness of its own Parkinson's diseas...

Actinogen reports new period 2 information to recover depression medication

.Actinogen Medical's chances-- and sell price-- have rebounded slightly coming from earlier this mon...

Pfizer as well as Crown jewel add Ratio to multibillion-dollar equation

.Flagship Pioneering and Pfizer have added Ratio right into their 10-program collaboration, inking a...

Bayer markers $547M pact to press borders of noncoding RNA

.Bayer managers were actually keen to worry to Strong this summertime that the German pharma titan's...